Agenus
AGEN
#8362
Rank
S$0.39 B
Marketcap
S$8.74
Share price
-3.53%
Change (1 day)
69.36%
Change (1 year)

Earnings for Agenus (AGEN)

Earnings in 2026 (TTM): S$0.19 Billion

According to Agenus 's latest financial reports the company's current earnings are S$0.13 Billion. In 2025 the company made an earning of S$66.72 Million, an increase over its 2024 earnings that were of -S$0.15 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Agenus from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) S$0.19 B191.61%
2025 S$66.72 M-145.52%
2024 -S$0.15 Billion-28.13%
2023 -S$0.21 Billion-5.5%
2022 -S$0.22 Billion-556.26%
2021 S$47.29 M-130.37%
2020 -S$0.16 Billion73.75%
2019 -S$89.64 Million-48.74%
2018 -S$0.18 Billion34.32%
2017 -S$0.14 Billion-7.16%
2016 -S$0.15 Billion26.55%
2015 -S$0.12 Billion110.24%
2014 -S$52.71 Million49.12%
2013 -S$35.35 Million
2011 -S$24.41 Million-12.25%
2010 -S$27.82 Million-21.41%
2009 -S$35.39 Million-26.86%
2008 -S$48.39 Million13.72%
2007 -S$42.55 Million-33.4%
2006 -S$63.89 Million-31.84%
2005 -S$93.73 Million9.74%
2004 -S$85.41 Million-0.8%
2003 -S$86.1 Million17.37%
2002 -S$73.36 Million37.83%
2001 -S$53.23 Million55.99%
2000 -S$34.12 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$33.50 B 17,251.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$9.83 B 4,991.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$15.22 B 7,785.43%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
S$10.08 B 5,123.53%๐Ÿ‡ฌ๐Ÿ‡ง UK
Celldex Therapeutics
CLDX
-S$0.42 Billion-315.73%๐Ÿ‡บ๐Ÿ‡ธ USA